CD4 and neoplasm: In vitro, PD-1 blockade potentiates activation of CD4 tumor-infiltrating lymphocytes, as manifested by elevated CD154 level and cytokine generation, contributing to the improvement of dendritic cell maturation and ultimately enhanced proliferation of tumor-specific CD8 T cells [110].